Paul E. Kelly - Director, Relmada Therapeutics, Inc

As of January 5, 2022


Paul E. Kelly Net Worth

  • Net worth is estimated to be at least $10.2M
  • Owns at least 167,295 units of Relmada Therapeutics, Inc stock
  • Sold an estimated value of $7.31M in the last 7 years at Relmada Therapeutics, Inc

Paul E. Kelly Trading

  • Largest purchase of shares was 373,483 units , worth over $295.91K on October 19, 2018
  • Largest sale of shares was 4,085 units , worth over $6.46M on January 26, 2021
  • In total has made about 19 transactions over 7 years
  • Usually trades in December, October and February, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Paul E. Kelly Mailing Address

  • Mailing address is 300 East 56th Street, Apt 19e New York, NY 10022 NY

Relmada Therapeutics, Inc Insider Trading

  • The most recent transaction was 6,600 units sold on September 24, 2021 by Charles J Casamento worth over $191.4K
  • In the last 6 years, insiders at Relmada Therapeutics, Inc sold an estimated value of $12.36M and bought an estimated value of $3.48M
  • The most active traders are Charles J Casamento, Director,  Paul E. Kelly, Director,  and Sergio Traversa, Chief Executive Officer
  • Insider trading is most common in December, with the busiest year in 2021

RELMADA THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1